catalog number :
MBS855039
products full name :
CSGLCAT Antibody
products short name :
CSGLCAT
products name syn :
Chondroitin sulfate glucuronyltransferase; EC 2.4.1.226; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase; Chondroitin glucuronyltransferase II; CSGlcA-T; CSGLCAT; KIAA1402; UNQ299/PRO339
other names :
chondroitin sulfate glucuronyltransferase isoform 1; Chondroitin sulfate glucuronyltransferase; chondroitin sulfate glucuronyltransferase; chondroitin synthase-3; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase; chondroitin polymerizing factor 2; CSGlcA-T; Chondroitin glucuronyltransferase; Chondroitin polymerizing factor 2; ChPF-2; Chondroitin synthase 3; ChSy-3; N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase
products gene name :
CSGLCAT
other gene names :
CHPF2; CHPF2; ChSy-3; chPF-2; CSGlcAT; CSGLCA-T; CHSY3; CSGLCAT; KIAA1402; ChPF-2; ChSy-3
uniprot entry name :
CHPF2_HUMAN
specificity :
CSGLCAT antibody detects endogenous levels of total CSGLCAT protein.
purity :
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
form :
Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol.
storage stability :
Store at -20 degree C for 1 year
tested application :
Western Blot (WB), ELISA (EIA)
app notes :
WB: 1:500~1:1000, ELISA: 1:40000
other info2 :
Immunogen: The antiserum was produced against synthesized peptide derived from internal of human CSGLCAT. Pathway: Translation
products categories :
Cancer; Cardiovascular; Cell Biology; Epigenetics & Nuclear Signaling; Developmental Biologys; Immunology; Drug Discovery Products; Metabolism; Neuroscience; Signal Transduction; Stem Cells; Autophagy antibody
products references :
Nagase T., DNA Res. 7:65-73(2000). Clark H.F., Genome Res. 13:2265-2270(2003). The MGC Project Team; Genome Res. 14:2121-2127(2004). ----------------------------------------------------------------------------------------------------------------------------------
ncbi acc num :
NP_061888.1
ncbi gb acc num :
NM_019015.2
ncbi mol weight :
74,527 Da
ncbi pathways :
Chondroitin Sulfate Biosynthesis Pathway (645309); Chondroitin Sulfate/dermatan Sulfate Metabolism Pathway (645308); Disease Pathway (530764); Glycogen Storage Diseases Pathway (980468); Glycosaminoglycan Biosynthesis - Chondroitin Sulfate / Dermatan Sulfate Pathway (82982); Glycosaminoglycan Biosynthesis - Chondroitin Sulfate / Dermatan Sulfate Pathway (356); Glycosaminoglycan Biosynthesis, Chondroitin Sulfate Backbone Pathway (413364); Glycosaminoglycan Biosynthesis, Chondroitin Sulfate Backbone Pathway (468251); Glycosaminoglycan Metabolism Pathway (645297); MPS I - Hurler Syndrome Pathway (685537)
uniprot summary :
CSGlcA-T: Transfers glucuronic acid (GlcUA) from UDP-GlcUA to N- acetylgalactosamine residues on the non-reducing end of the elongating chondroitin polymer. Has no N- acetylgalactosaminyltransferase activity. Belongs to the chondroitin N- acetylgalactosaminyltransferase family. 2 isoforms of the human protein are produced by alternative splicing. Protein type: Membrane protein, integral; Transferase; EC 2.4.1.226; Glycan Metabolism - chondroitin sulfate biosynthesis. Chromosomal Location of Human Ortholog: 7q36.1. Cellular Component: Golgi membrane; membrane; integral to membrane. Molecular Function: N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity; acetylgalactosaminyltransferase activity. Biological Process: chondroitin sulfate metabolic process; chondroitin sulfate biosynthetic process; glycosaminoglycan metabolic process; carbohydrate metabolic process; pathogenesis